Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Vytrus Biotech SA
MAD:VYT
Vytrus Biotech SA
MAD:VYT
Price:
15
EUR
4.17%
Market Closed
Market Cap:
€114.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vytrus Biotech SA
MAD:VYT
|
ES |
|
S
|
Starpharma Holdings Ltd
OTC:SPHRY
|
AU |
|
J
|
Johnson & Johnson
DUS:JNJ
|
US |
|
T
|
Tandy Leather Factory Inc
NASDAQ:TLF
|
US |
|
Wereldhave Belgium NV
XBRU:WEHB
|
BE |
|
S
|
Shinsung Delta Tech Co Ltd
KOSDAQ:065350
|
KR |
|
Piquadro SpA
MIL:PQ
|
IT |
|
Swiss Prime Site AG
OTC:SWPRF
|
CH |
|
E
|
Evoke PLC
OTC:EIHDF
|
GI |
|
Laureate Education Inc
NASDAQ:LAUR
|
US |
|
Heineken NV
F:HNK1
|
NL |
|
N
|
Nice Information & Telecommunication Inc
KOSDAQ:036800
|
KR |
|
Antofagasta PLC
LSE:ANTO
|
UK |
|
Vidrala SA
F:VIR
|
ES |
|
M
|
MFEC PCL
SET:MFEC
|
TH |
|
Azelis Group NV
LSE:0AA6
|
BE |
|
B
|
Bitcoin Group SE
DUS:ADE
|
DE |
|
P
|
PLDT Inc
F:PLO
|
PH |
|
C
|
CIMC Enric Holdings Ltd
HKEX:3899
|
CN |
Wall St Price Targets
VYT Price Forecast
Based on 3 analysts
Based on 3 analysts
+9% Upside
from
€15
today
Vytrus Biotech SA (VYT)’s 12-month stock price forecast through November 2027 has a consensus target of €16.34, implying 9% upside. The forecast is based on price targets from 3 Wall Street analysts.
VYT Analyst Rating
No ratings yet
No ratings yet
Vytrus Biotech SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VYT's stock price target?
Price Target
16.34
EUR
16.34
EUR
According to Wall Street analysts, the average 1-year price target for VYT is 16.34 EUR with a low forecast of 16.18 EUR and a high forecast of 16.82 EUR.
What is the Revenue forecast for Vytrus Biotech SA?
Projected CAGR
23%
23%
Over the last 6 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 3 years is 23%.
What is the Operating Income forecast for Vytrus Biotech SA?
Projected CAGR
27%
27%
The compound annual growth rate for Operating Income over the next 3 years is 27%.
